1.) Development of creative solutions for solving healthcare related problems
2.) Helping patients achieve the best quality of life that they desire

As the founder of ImmunoMetabolix, Abhinav aims to utilize the formulations developed to modulate the metabolism of immune system to resolve immune related disorders in patients.
ImmunoMetabolix Is a clinical-stage biotechnology company focused on applying a novel engineering approach to develop metabolically-fit immunotherapies for patients with cancer, autoimmune, and inflammatory diseases.

Abhinav Acharya is an Assistant Professor in the Department of Chemical Engineering at the Arizona State University. He earned his Master’s and Ph.D. in Materials Science and Engineering at the University of Florida, Gainesville and was a postdoctoral scholar at the University of California, Berkeley and University of Pittsburgh. He started as an assistant professor at Arizona State University in January 2019. Acharya’s research expertise is in formulations, and immunology, with a particular emphasis on technology development. He is an active member of Society for Biomaterials, and Controlled Release Society.